Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide. [electronic resource]
Producer: 20010830Description: 188-99 p. digitalISSN:- 0270-4137
- Androgens -- pharmacology
- Animals
- Cyclic AMP -- biosynthesis
- Disease Progression
- Dose-Response Relationship, Drug
- Gene Expression Regulation, Neoplastic
- Growth Hormone-Releasing Hormone -- antagonists & inhibitors
- Male
- Mice
- Prostate-Specific Antigen -- biosynthesis
- Prostatic Neoplasms -- genetics
- Tumor Cells, Cultured
- Vasoactive Intestinal Peptide -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.